FDA/Duke Partnership Will Work On Cardiac Markers, Form Consortium
Executive Summary
FDA's partnership with the Duke Clinical Research Institute to develop tools for identifying the potential cardiac effects of drugs and devices will examine gender differences as one of its first projects